on NOVACYT (EPA:ALNOV)
Novacyt publishes its monthly liquidity contract data
Novacyt SA, a molecular diagnostics company, has released its monthly balance sheet for September 2025 for shares traded under its liquidity agreement with Invest Securities SA. During this period, 16,600 ordinary shares were purchased and 18,216 sold, with prices ranging from €0.44 to €0.49.
The liquidity agreement, governed by French law, allows Invest Securities to manage share purchases for Novacyt within certain limits set by shareholders. At the end of September, Novacyt held 104,912 treasury shares.
Novacyt, listed on the AIM and Euronext Growth markets, has a total of 70,626,248 shares. This information is essential for shareholders, particularly when assessing their stake in the company.
R. P.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all NOVACYT news